There were statistically significant differences among MM staging groups in NT-proBNP levels, M-protein concentration, proportion of non-IgG isotypes, and levels of B2M, creatinine, LDH, hemoglobin, and platelet count (p < 0.001). This evidence concerns the gene B2M and Miyoshi myopathy.